Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics
Kyung Chan Park, Leyla Fouani, Patric J. Jansson, et al.
Metallomics (2016) Vol. 8, Iss. 9, pp. 874-886
Closed Access | Times Cited: 123

Showing 26-50 of 123 citing articles:

The coordination modes of (thio)semicarbazone copper(II) complexes strongly modulate the solution chemical properties and mechanism of anticancer activity
Vivien Pósa, Bálint Hajdu, Gábor G. Tóth, et al.
Journal of Inorganic Biochemistry (2022) Vol. 231, pp. 111786-111786
Closed Access | Times Cited: 31
Phenanthroline and Schiff Base associated Cu(II)-coordinated compounds containing N, O as donor atoms for potent anticancer activity
Richa Richa, Vinod Kumar, Ramesh Kataria
Journal of Inorganic Biochemistry (2023) Vol. 251, pp. 112440-112440
Closed Access | Times Cited: 19
Thiosemicarbazone Mixed-Valence Cu(I/II) Complex against Lung Adenocarcinoma Cells through Multiple Pathways Involving Cuproptosis
Aili Li, Kai Huang, Wei‐Ping Pan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9091-9103
Closed Access | Times Cited: 6
Copper(ii) Complexes Based on 2,2’-Bipyridine and 1,10-Phenanthroline as Potential Objects for Developing Antitumor Drugs
Yu. A. Golubeva, Е.В. Лидер
Journal of Structural Chemistry (2024) Vol. 65, Iss. 6, pp. 1159-1209
Closed Access | Times Cited: 6
Reactivity of Cu(ii)–, Zn(ii)– and Fe(ii)–thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation
Alice Santoro, Bertrand Vileno, Òscar Palacios, et al.
Metallomics (2019) Vol. 11, Iss. 5, pp. 994-1004
Closed Access | Times Cited: 46
Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology
George J. Kontoghiorghes, Christina Kontoghiorghe
Expert Opinion on Investigational Drugs (2019) Vol. 28, Iss. 7, pp. 593-603
Closed Access | Times Cited: 46
Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex
Ping Yu, JunGang Deng, Jinhua Cai, et al.
Metallomics (2019) Vol. 11, Iss. 8, pp. 1372-1386
Closed Access | Times Cited: 45
Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux
Julia H. Bormio Nunes, Sonja Hager, Marlene Mathuber, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13719-13732
Open Access | Times Cited: 45
Synthesis, characterisation and biological studies of mixed-ligand nickel (II) complexes containing imidazole derivatives and thiosemicarbazide Schiff bases
Nurul N. M. Ishak, Junita Jamsari, Ahmad Zaidi Ismail, et al.
Journal of Molecular Structure (2019) Vol. 1198, pp. 126888-126888
Open Access | Times Cited: 43
Targeting of the intracellular redox balance by metal complexes towards anticancer therapy
María Isabel Murillo, Christian Gaiddon, Ronan Le Lagadec
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 24
Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis
Xiaojun Wang, Minghui Zhu, Shanhe Li, et al.
Journal of Inorganic Biochemistry (2023) Vol. 250, pp. 112403-112403
Closed Access | Times Cited: 15
A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer
Weibin Lian, Peidong Yang, Liangqiang Li, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment
Dahye Noh, Hokyung Lee, Sangmin Lee, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 5
In vitro antioxidant, antiinflammatory and in silico molecular docking studies of thiosemicarbazones
G.R. Subhashree, Jebiti Haribabu, Saranya Sivaraj, et al.
Journal of Molecular Structure (2017) Vol. 1145, pp. 160-169
Closed Access | Times Cited: 48
Exposure to Trace Elements and Risk of Skin Cancer: A Systematic Review of Epidemiologic Studies
Natalie H. Matthews, K. Fitch, Wenqing Li, et al.
Cancer Epidemiology Biomarkers & Prevention (2018) Vol. 28, Iss. 1, pp. 3-21
Open Access | Times Cited: 43
Developing an Anticancer Copper(II) Multitarget Pro-Drug Based on the His146 Residue in the IB Subdomain of Modified Human Serum Albumin
Jun Wang, Yi Gou, Zhenlei Zhang, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 6, pp. 2180-2193
Closed Access | Times Cited: 41
Cytotoxic cobalt (III) Schiff base complexes: in vitro anti-proliferative, oxidative stress and gene expression studies in human breast and lung cancer cells
Balakrishnan Gowdhami, Yesaiyan Manojkumar, R.T.V. Vimala, et al.
BioMetals (2021) Vol. 35, Iss. 1, pp. 67-85
Closed Access | Times Cited: 30
Theoretical Studies of Copper(II) Hydroxamate Complexes: Molecular Structures, HOMO–LUMO Study, Reactivity Descriptors, Spectral Analyses, and Molecular Docking Study
Vineet Kumar Choudhary, Parul Chauhan, Kanika Mandhan, et al.
Russian Journal of Inorganic Chemistry (2025)
Closed Access
HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model
Yi Gou, Zhenlei Zhang, Dongyang Li, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 321-329
Open Access | Times Cited: 35
Structural analysis and biological functionalities of iron(III)– and manganese(III)–thiosemicarbazone complexes: in vitro anti-proliferative activity on human cancer cells, DNA binding and cleavage studies
Büşra Kaya, Zehra Kübra Yılmaz, Onur Şahın, et al.
JBIC Journal of Biological Inorganic Chemistry (2019) Vol. 24, Iss. 3, pp. 365-376
Closed Access | Times Cited: 33
Bifunctional ligand design for modulating mutant p53 aggregation in cancer
Jessica J. Miller, Anaïs Blanchet, Christophe Orvain, et al.
Chemical Science (2019) Vol. 10, Iss. 46, pp. 10802-10814
Open Access | Times Cited: 32
Progress in the research of cuproptosis and possible targets for cancer therapy
Jiang Wang, Lanzhu Luo, Daomiao Liang, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 9, pp. 324-334
Open Access | Times Cited: 9
Troxerutin with copper generates oxidative stress in cancer cells: Its possible chemotherapeutic mechanism against hepatocellular carcinoma
Subastri Ariraman, Suyavaran Arumugam, E. Preedia Babu, et al.
Journal of Cellular Physiology (2017) Vol. 233, Iss. 3, pp. 1775-1790
Closed Access | Times Cited: 33
Synthesis, characterization, and anticancer activity of two mixed ligand copper(ii) complexes by regulating the VEGF/VEGFR2 signaling pathway
Xiu‐Ying Qin, Ya-Nan Wang, Xinping Yang, et al.
Dalton Transactions (2017) Vol. 46, Iss. 47, pp. 16446-16454
Closed Access | Times Cited: 33
Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity
R. Moussa, Kyung Chan Park, Žaklina Kovačević, et al.
Free Radical Biology and Medicine (2018) Vol. 133, pp. 276-294
Closed Access | Times Cited: 32

Scroll to top